Using a peptide segment to covalently conjugate doxorubicin and taxol for the study of drug combination effect

Ya Ling, Yuan Gao, Chang Shu, Ying Zhou, Wenying Zhong*, Bing Xu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Abstract

Doxorubicin (Dox) and Taxol can be covalently bonded to the same peptide segment via proper structural modification. Doxorubicin-maleimide derivative links to peptide via Michael addition reaction and Taxol-Succi-NHS active ester connects to the same peptide backbone through ester-amide exchange reaction. Enzymatic transformation, as an inherent biological process, is applied here to trigger the formation of nanofiber networks from the as prepared hydrogelator precursor. The precursor which loads equal molar ratio of Dox and Taxol can self-assemble to form a red stable hydrogel after dephosphorylation reaction catalyzed by alkaline phosphatase (ALP). This hydrogel could maintain sustained release of drugs and show strong anticancer effect. This work, as a new strategy to build a co-delivery system of covalently linked Dox and Taxol, owns the potential to serve as an injectable hydrogel for therapeutic applications.

Original languageEnglish
Pages (from-to)101475-101479
Number of pages5
JournalRSC Advances
Volume5
Issue number123
DOIs
Publication statusPublished - 17 Nov 2015
Externally publishedYes

Fingerprint

Dive into the research topics of 'Using a peptide segment to covalently conjugate doxorubicin and taxol for the study of drug combination effect'. Together they form a unique fingerprint.

Cite this